Showing results (371-380 of 496) with videos related to
Sort By:
Pageof 50
Advances in Neurology|January 1, 1987
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenylP Riederer, C Konradi, V Schay, et al.Journal of Neural Transmission. Supplementum|April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseasesE Sofic, A Sapcanin, I Tahirovic, et al.Journal of Neurochemistry|February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brainsP Riederer, E Sofic, W D Rausch, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorderG Laux, W Classen, E Sofic, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communicationG Stöber, S Jatzke, A Heils, et al.Journal of Neuroscience Research|August 1, 1996
U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transportersE Koutsilieri, J Kornhuber, H J Degen, et al.Dementia and Geriatric Cognitive Disorders|April 3, 1998
Platelet monoamine oxidase B activity in dementia. A 4-year follow-upM E Götz, P Fischer, W Gsell, et al.Journal of Neurochemistry|March 22, 2001
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processesL Zecca, M Gallorini, V Schünemann, et al.European Neurology|January 1, 1996
Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseasesB Janetzky, C Schmid, F Bischof, et al.Journal of Neural Transmission. Supplementum|January 1, 1997
Molecular heterogeneity of neurotransporters: implications for neurodegenerationK P Lesch, U Balling, M Seemann, et al.Pageof 50